04/25/2024
6:18 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
8:52 PM | Vistagen Therapeutics (Filer)
| Form DEF 14A | |
04/05/2024
4:29 PM | Vistagen Therapeutics (Filer)
| Form PRE 14A | |
03/06/2024
5:00 PM | SAXE JON S (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | Cunningham Ann Michelle (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | Curley Joanne (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | FitzPatrick Margaret M (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/06/2024
5:00 PM | GIN JERRY B (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | Rotunno Mary L. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
11:15 PM | Vistagen Therapeutics (Filer)
| Form EFFECT | |
02/14/2024
5:18 PM | CITADEL ADVISORS LLC (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:56 AM | Point72 Asset Management, L.P. (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
5:27 PM | StemPoint Capital LP (Filed by)
Vistagen Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/03/2024
4:17 PM | Singh Shawn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:19 PM | Adler Reid G. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:09 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
3:44 PM | Vistagen Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
8:46 PM | Vistagen Therapeutics (Filer)
| Form 8-K/A | |
11/06/2023
3:27 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
7:14 PM | Prince Joshua S. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
3:34 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/16/2023
3:37 PM | TCG Crossover GP II, LLC (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/16/2023
3:01 PM | CITADEL ADVISORS LLC (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/12/2023
3:04 PM | GREAT POINT PARTNERS LLC (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/06/2023
3:05 PM | COMMODORE CAPITAL LP (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
10/06/2023
3:05 PM | COMMODORE CAPITAL LP (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
3:47 PM | Point72 Asset Management, L.P. (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/02/2023
6:15 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2023
3:26 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
7:43 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
4:27 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2023
12:08 PM | Anderson Cynthia Lynn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/23/2023
12:09 PM | Anderson Cynthia Lynn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
7:40 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
7:00 AM | Vistagen Therapeutics (Filer)
| Form 424B5 | |
08/07/2023
7:35 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/28/2023
3:54 PM | Vistagen Therapeutics (Filer)
| Form DEF 14A | |
07/28/2023
3:55 PM | Vistagen Therapeutics (Filer)
| Form DEFA14A | |
07/18/2023
5:02 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
3:35 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2023
3:35 PM | BlackRock Inc. (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
Everybody laughed when he recommended Netflix (Ad) "This Could be Worth Even More than A.I."
Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. |
06/28/2023
4:11 PM | Vistagen Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
06/28/2023
3:28 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
7:35 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:43 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
4:30 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
3:33 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
8:26 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
